FI3607055T3 - Koostumuksia solujen uudelleenohjelmoimiseksi dendriittisoluiksi tai antigeeniä esitteleviksi soluiksi, niiden menetelmiä ja käyttötapoja - Google Patents

Koostumuksia solujen uudelleenohjelmoimiseksi dendriittisoluiksi tai antigeeniä esitteleviksi soluiksi, niiden menetelmiä ja käyttötapoja

Info

Publication number
FI3607055T3
FI3607055T3 FIEP18723960.3T FI18723960T FI3607055T3 FI 3607055 T3 FI3607055 T3 FI 3607055T3 FI 18723960 T FI18723960 T FI 18723960T FI 3607055 T3 FI3607055 T3 FI 3607055T3
Authority
FI
Finland
Prior art keywords
cancer
seq
cell
batf3
irf8
Prior art date
Application number
FIEP18723960.3T
Other languages
English (en)
Finnish (fi)
Inventor
Lemos Pereira Carlos Filipe Ribeiro
Pires Cristiana Ferreira
Rosa Fábio Alexandre Fiúza
Original Assignee
Asgard Therapeutics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP17171166.6A external-priority patent/EP3385373A1/en
Application filed by Asgard Therapeutics Ab filed Critical Asgard Therapeutics Ab
Priority claimed from PCT/IB2018/052378 external-priority patent/WO2018185709A1/en
Application granted granted Critical
Publication of FI3607055T3 publication Critical patent/FI3607055T3/fi

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FIEP18723960.3T 2017-04-05 2018-04-05 Koostumuksia solujen uudelleenohjelmoimiseksi dendriittisoluiksi tai antigeeniä esitteleviksi soluiksi, niiden menetelmiä ja käyttötapoja FI3607055T3 (fi)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PT2017110012 2017-04-05
EP17171166.6A EP3385373A1 (en) 2017-04-05 2017-05-15 Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof
PT2017110263 2017-08-24
PT2017110267 2017-08-25
PCT/IB2018/052378 WO2018185709A1 (en) 2017-04-05 2018-04-05 Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof

Publications (1)

Publication Number Publication Date
FI3607055T3 true FI3607055T3 (fi) 2025-07-29

Family

ID=96498744

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP18723960.3T FI3607055T3 (fi) 2017-04-05 2018-04-05 Koostumuksia solujen uudelleenohjelmoimiseksi dendriittisoluiksi tai antigeeniä esitteleviksi soluiksi, niiden menetelmiä ja käyttötapoja

Country Status (3)

Country Link
ES (1) ES3035814T3 (pl)
FI (1) FI3607055T3 (pl)
PL (1) PL3607055T3 (pl)

Also Published As

Publication number Publication date
ES3035814T3 (en) 2025-09-09
PL3607055T3 (pl) 2025-09-08

Similar Documents

Publication Publication Date Title
JP2020513191A5 (pl)
JP2024522074A5 (pl)
Ji et al. Identification of microRNA‐181 by genome‐wide screening as a critical player in EpCAM–positive hepatic cancer stem cells
Buccini et al. Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart
Kermani et al. Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: potential application in cell-based gene therapy
US10799474B2 (en) Method of treating leukemia utilizing somatic cell reprogramming
Khosravi et al. Differentiation of umbilical cord derived mesenchymal stem cells to hepatocyte cells by transfection of miR-106a, miR-574-3p, and miR-451
RU2018105986A (ru) Сконструированные эндотелиальные клетки, экспрессирующие фактор транскрипции ets
Asgharzadeh et al. Upregulation of miR-210 promotes differentiation of mesenchymal stem cells (MSCs) into osteoblasts
EP2799552B1 (en) Method capable of massively and rapidly inducing mesenchymal stem cells to transdetermine into hematopoietic stem cells of high purity
CN104845932A (zh) 淫羊藿苷的新用途
Himal et al. Evaluating Wharton’s Jelly‐Derived Mesenchymal Stem Cell’s Survival, Migration, and Expression of Wound Repair Markers under Conditions of Ischemia‐Like Stress
JP2023506707A5 (pl)
CN107148470A (zh) 上调癌干细胞标志物以产生抗原特异性细胞毒性效应t细胞的方法
CN104593421A (zh) 一种抑制胶质瘤生长的过表达bdnf的间充质干细胞的制备方法及其临床应用
JP7743980B2 (ja) ヒトＴ細胞由来ｉＰＳ細胞由来の細胞傷害性Ｔ細胞
US20160024469A1 (en) Non-conventional Cellular Based Immunotherapy
FI3607055T3 (fi) Koostumuksia solujen uudelleenohjelmoimiseksi dendriittisoluiksi tai antigeeniä esitteleviksi soluiksi, niiden menetelmiä ja käyttötapoja
JP7718819B2 (ja) 成体幹細胞の拡大と誘導のインビトロでの誘発
CN104673831B (zh) 一种维持和恢复人毛乳头细胞原始性的方法及其应用
Ren et al. Apoptosis inhibition enhances induced pluripotent stem cell generation during T cell reprogramming
CN114752625A (zh) 一种山羊源oskm及其构建方法与应用
Liu et al. Differentiation of genetically modified canine bone mesenchymal stem cells labeled with superparamagnetic iron oxide into neural‑like cells
KR102121417B1 (ko) Stat3 활성화제를 이용한 골격근세포 분화 유도용 조성물 및 이를 이용한 골격근세포 분화 유도 방법
Lu et al. EZH2 suppresses hepatocellular differentiation of mouse bone marrow mesenchymal stem cells